Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

UroLift as a surrogate for fiducial markers in IGRT planning of prostate cancer in BPH patients.

Biswal NC, Swann B, McKenna MG, Singh R.

Pract Radiat Oncol. 2018 Jul - Aug;8(4):e231-e233. doi: 10.1016/j.prro.2017.11.014. Epub 2017 Dec 24. No abstract available.

PMID:
29452872
2.

Radiotherapy with 6-megavolt photons for early glottic carcinoma: potential impact of extension to the posterior vocal cord.

Lee JH, Machtay M, McKenna MG, Weinstein GS, Markiewicz DA, Krisch RE, Kligerman MM.

Am J Otolaryngol. 2001 Jan-Feb;22(1):43-54. Review.

PMID:
11172214
3.

Factors predicting severe radiation pneumonitis in patients receiving definitive chemoradiation for lung cancer.

Robnett TJ, Machtay M, Vines EF, McKenna MG, Algazy KM, McKenna WG.

Int J Radiat Oncol Biol Phys. 2000 Aug 1;48(1):89-94.

PMID:
10924976
4.

Non-small cell lung cancer: prognostic factors in patients treated with surgery and postoperative radiation therapy.

Lee JH, Machtay M, Kaiser LR, Friedberg JS, Hahn SM, McKenna MG, McKenna WG.

Radiology. 1999 Dec;213(3):845-52.

PMID:
10580965
5.

Calculation of the dose in the build-up region for high energy photon beam. Treatment planning when beam spoilers are employed.

McKenna MG, Chen XG, Altschuler MD, Bloch P.

Radiother Oncol. 1995 Jan;34(1):63-8.

PMID:
7792400

Supplemental Content

Loading ...
Support Center